The article focuses on a study which examined the cost effectiveness of positron emission tomography (PET) scanning for lung cancer. The study simulated the cost effectiveness of a noninvasive and an invasive staging strategy for non-small cell lung cancer using a mathematical model. It concluded ...
The PET scanner is a tubular machine equipped with a hard, flat table. You will be asked to lie flat on the table, and you will enter the machine for scanning, which can take up to an hour. During this time, you will have to lie very still. You will be able to communicate any d...
主要参考文献: Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med. 2007 Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology. 2009 Report on the development and application of...
Positron emission tomography (PET) scanning is increasingly being used for imaging a variety of cancers, including urologic cancers. The precise utility of PET scanning for bladder cancer, prostate cancer, and renal cell carcinoma (RCC) is not yet well known. We examined the trends in PET scan...
Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med. 2007 Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology. 2009 Report on the development and application of PET/CT in mainland China. Oncotarget. 2017 ...
Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer PurposeThe aim of this study was to evaluate the potential of 18F-fluorothymidine (FLT) PET/CT for imaging pancreatic adenocarcinoma. A Quon,ST Chang,F Chin,... - 《Other》 被引量: 0发表: 2008年...
Positron Emission Tomography Scanning: Current and Future Applications FDG-PET has recently been approved by the Health Care Finance Administration for Medicare reimbursement for diagnosing, staging, and restaging lung cancer, ... J Czernin,ME Phelps - 《Annual Review of Medicine》 被引量: 603发表:...
We evaluated the place of PET scanning in the characterization of additional abnormalities discovered on routine, preoperative CT evaluation of patients with proven NSCLC. Between October 1995 and November 1996, 20 patients underwent PET scanning using 2-18 F fluorodeoxyglucose (FDG). 10 patients were...
In patients with non-small cell lung carcinoma (NSCLC) fluorine-18 fluorodeoxyglucose positron emission tomography (18FDG-PET)-scanning is shown to be of prognostic value. Small cell lung cancer (SCLC) is an aggressive tumor with poor prognosis. Limited results on the prognostic and predictive val...
Andrew M. Scott, director of the Centre for PET and the Ludwig Institute for Cancer Research, at Austin Hospital in Melbourne, Australia, involved 191 patients who underwent PET scanning. Prior to the scanning, they were divided into two groups: Group A patients showed symptoms and had ...